Status:
ACTIVE_NOT_RECRUITING
The Effect of Enhanced Recovery After Surgery (ERAS) in Gastric Cancer Surgery
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Anesthesiology
General Surgery
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The investigators aimed to clarify the clinical relevance of the ERAS protocol by evaluating the perioperative course in patients undergoing laparoscopic gastric cancer surgery.
Detailed Description
Gastric cancer is 7th common malignant disease in Taiwan, accounting for 3000 new cases per year. The main treatment of gastric cancer is radical gastrectomy and lymph nodes dissection, which is assoc...
Eligibility Criteria
Inclusion
- Pathological confirmed as gastric adenocarcinoma;
- Gastric cancer patients who will undergo subtotal gastrectomy.
Exclusion
- Advanced gastric cancer with gastric outlet obstruction;
- Epidural catheter placement contraindicated or inexecutable;
- Have other cancers that have received chemotherapy or radiation therapy;
- Coagulation abnormalities;
- Pregnancy;
- Severe dysfunction of major organs (e.g., heart failure, chronic obstructive pulmonary disease, liver cirrhosis, end-stage renal disease)
Key Trial Info
Start Date :
December 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06209983
Start Date
December 5 2018
End Date
December 31 2027
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan